The WHO launched a voluntary Covid-19 product pool. What happens next?
After weeks of planning, the World Health Organization formally launched a voluntary pool to collect patent rights, regulatory test data, and other information that could be shared for developing drugs, vaccines, and diagnostics to combat Covid-19.
The effort reflects rising concern that some Covid-19 medical products may not be accessible for poorer populations – in any country. By establishing a voluntary mechanism under the auspices of the WHO, the goal is to create a pathway to attract numerous governments, as well as industry, universities and nonprofit organizations.
Read Original Article: The WHO launched a voluntary Covid-19 product pool. What happens next? »
